Showing results (181-190 of 224) with videos related to
Sort By:
Pageof 23
Proceedings of the National Academy of Sciences of the United States of America|December 22, 2010
Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutationsKatherine A Janeway, Su Young Kim, Maya Lodish, et al.Journal of Adolescent and Young Adult Oncology|September 13, 2021
Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321Viswatej Avutu, Aaron R Weiss, Damon R Reed, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2020
DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumorJunne Kamihara, Vera Paulson, Micheál A Breen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 15, 2021
Phase III Trial Adding Vincristine-Topotecan-Cyclophosphamide to the Initial Treatment of Patients With Nonmetastatic Ewing Sarcoma: A Children's Oncology Group ReportPatrick J Leavey, Nadia N Laack, Mark D Krailo, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2017
Cancer Screening Recommendations for Individuals with Li-Fraumeni SyndromeChristian P Kratz, Maria Isabel Achatz, Laurence Brugières, et al.Journal of the National Cancer Institute|May 25, 2023
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621CSusan N Chi, Joanna S Yi, P Mickey Williams, et al.The Oncologist|June 14, 2024
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm GMarie V Nelson, AeRang Kim, P Mickey Williams, et al.The Lancet. Oncology|November 13, 2018
Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohortTodd M Gibson, Sogol Mostoufi-Moab, Kayla L Stratton, et al.Pediatric Blood & Cancer|April 19, 2023
Vincristine/irinotecan/temsirolimus upfront window treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 Study CommitteePatrick A Thompson, Marcio H Malogolowkin, Wayne L Furman, et al.Clinical Orthopaedics and Related Research|May 18, 2022
What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study ReportErik J Geiger, Wei Liu, Deo Kumar Srivastava, et al.Pageof 23